Sep 3, 2026 08:33AM
Sep 3, 2026 08:30AM
Apr 28, 2026 08:00AM
Mar 18, 2026 09:00AM
Mar 18, 2026 08:15AM
Mar 11, 2026 10:00AM
Dec 1, 2025 07:01AM KALA BIO receives $6M investment, appoints new CEO
Dec 1, 2025 07:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 8, 2025 08:00AM
May 14, 2025 08:00AM
Mar 31, 2025 08:00AM KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Nov 12, 2024 08:00AM
Aug 6, 2024 08:00AM
May 14, 2024 04:05PM
Mar 29, 2024 08:00AM
Nov 13, 2023 08:00AM
Aug 4, 2023 08:00AM
May 9, 2023 08:00AM Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Mar 3, 2023 08:02AM
Mar 3, 2023 08:00AM
Mar 3, 2023 08:00AM
Nov 8, 2022 08:00AM
Nov 8, 2022 08:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
May 16, 2022 07:00AM
May 16, 2022 07:00AM
May 3, 2022 08:03AM
May 3, 2022 08:00AM
May 3, 2022 08:00AM
May 1, 2022 09:00AM
May 1, 2022 09:00AM Kala Pharmaceuticals to Present Clinical Data for KPI-012, its Mesenchymal Stem Cell Secretome Product, for the Treatment of PCED at the 2022 ARVO Annual Meeting
Mar 29, 2022 07:04AM
Mar 29, 2022 07:00AM
Mar 29, 2022 07:00AM
Mar 8, 2022 08:10AM
Mar 8, 2022 08:00AM
Mar 8, 2022 08:00AM
Dec 15, 2021 06:25AM UPDATE: Wedbush Assumes Kala Pharmaceuticals (KALA) at Outperform
Nov 18, 2021 04:01PM
Nov 18, 2021 04:01PM
Nov 15, 2021 08:47AM
Nov 15, 2021 08:47AM
Nov 15, 2021 08:45AM
Nov 15, 2021 08:45AM
Nov 15, 2021 08:45AM Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Dise
Nov 16, 2020 07:08AM

1,188,218 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All